25, July 2024: Abraham S et al. Beneficial modulation of gut microbiome and Neutrophil-Lymphocyte ratio (NLR) by Nichi Glucan and its potentials as an adjuvant in malignant tumors of the pancreas and liver. 61st Annual Meeting of the Japanese Society of Surgical Metabolism and Nutrition. Osaka, Japan.

16~19, May 2024: Abraham S et al. Novel B-glucan based disease modifying treatment adjuvant in Duchenne muscular dystrophy.Concurrent Sessions: Duchenne muscular dystrophy. MENA Congress for Rare Diseases. Abu Dhabi, UAE.

15~19, October 2023: Abraham S et al. Beneficial changes of gut microbiome commonly relevant to multiple sclerosis and Duchenne muscular dystrophy (DMD) after consumption of A.pullulansN-163-B-glucan –Results from clinical studies XXVI World Congress of Neurology (WCN2023), Montreal, Canada.